StrategyDrug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug Prices
PhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
Clinical CareMany Hospitals Still Don't Have Drug Diversion Programs
CDC information shows the increase in the frequency of disease outbreaks stemming from drug diversion.
Clinical CareNIOSH Seeks Comment on Updated List of Hazardous Drugs in Healthcare
The list, which is a basic reference document for OSHA, USP and other standard-setting organizations, has not been updated since...
Clinical CareNIH: Clinical Trial Shows Remdesivir Improves Coronavirus Outcomes
A study involving more than 1,000 patients finds remdesivir speeds coronavirus recovery and lowers mortality rate by 3.6 percentage points.
InnovationFDA Takes 'Aggressive' Measures to Stimulate COVID-19 Pharmaceutical Solutions
Trump and FDA Commissioner outline mechanisms being used to access drugs, cite specific therapies that could be approved within months....
Clinical CareHeart Association Puts Halt To Bayer's Giant Displays Of Baby Aspirin
The American Heart Association says that although aspirin can help people with previous heart attacks or strokes, its risks generally...
InnovationMayo Clinic Designs Novel Data Privacy Model; Announces Venture to Accelerate Drug Discovery
From the J.P. Morgan Healthcare Conference, the healthcare system shares details about balancing innovation with the need to protect patient...
Clinical CareDoctor and Patient Education Cuts PPI Use
Big drop in scripts after interventions in Texas program.
FinanceDoctors Prescribe More of a Drug If They Receive Money from a Pharma Company Tied to It
Drug companies have paid doctors billions of dollars for consulting, promotional talks, meals and more. A new ProPublica analysis finds...
StrategyWhy Insulin Is Ineligible for Buyer-Led Drug Importation Under Trump's Proposal
The administration points to statutory language, including definitions amended by the ACA, as preventing that FDA from allowing states to...
Clinical CareWarfarin Is Bad to the Bone, Fracture Data Affirms
In U.S. claims analysis, fracture risk lower with DOACs
StrategyBristol-Myers Squibb Completes $74B Celgene Acquisition
The transaction closed after the parties agreed to sell off a major psoriasis drug.